Rosuvastatin Completed Phase 4 Trials for Cardiovascular Heart Disease / Atherosclerosis Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00851175Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?